Cardiac xenotransplantation technology provides materials for improved bioprosthetic heart valves
- 31 January 2011
- journal article
- Published by Elsevier BV in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 141 (1), 269-275
- https://doi.org/10.1016/j.jtcvs.2010.08.064
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Proteomic identification of non‐Gal antibody targets after pig‐to‐primate cardiac xenotransplantationXenotransplantation, 2008
- Pathological findings in explanted prosthetic heart valves from ventricular assist devicesPathology, 2008
- Glutaraldehyde-Fixed Bioprosthetic Heart Valve Conduits Calcify and Fail From Xenograft RejectionCirculation, 2006
- Cardiac xenotransplantation: Recent preclinical progress with 3-month median survivalThe Journal of Thoracic and Cardiovascular Surgery, 2005
- Pig cells that lack the gene for α1-3 galactosyltransferase express low levels of the gal antigenTransplantation, 2003
- Evaluation of Different α-Galactosyl Glycoconjugates for Use in XenotransplantationBioconjugate Chemistry, 2002
- THE ROLE OF ANTI-GAL??1-3GAL ANTIBODIES IN ACUTE VASCULAR REJECTION AND ACCOMMODATION OF XENOGRAFTS1Transplantation, 2000
- Anti-Galα1-3Gal IgM/IgG antibody levels in infants: do they have a clinical relevance in pediatric xenotransplantation?The Journal of Heart and Lung Transplantation, 2000
- Depletion of anti‐Galα1–3Gal antibody in baboons by specific α‐Gal immunoaffinity columnsXenotransplantation, 1998
- Identification of α-galactosyl and other carbohydrate epitopes that are bound by human anti-pig antibodies: relevance to discordant xenografting in manTransplant Immunology, 1993